Cite
MLA Citation
S Danese et al.. “DOP54 Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S061–S062. http://access.bl.uk/ark:/81055/vdc_100094058986.0x00000c